This site requires JavaScript to render the code.

Need to know how to enable JavaScript? Go here.

Oct 2020 QIAsure Methylation Test validated as triage strategy for HPV positive women in a large multicenter European study
July 2020, NeuMoDx Molecular Receives CE Mark for HPV Diagnostic Test
Oct. 2019, FAM19A4/miR124-2 methylation shows higher sensitivity than cytology for detection of CIN3+ in women living with HIV
October 2019, HPV-Risk assay clinically validated on SurePath cervical screening samples
December 2018, Self-screen and Novosanis received a prestigious Eurostar grant
February 2019, Results from an international study confirm the robustness of the QIAsure Methylation Test